Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease?

Giovanni Raimondo1, Gaia Cacciamo, Carlo Saitta

  • 1Unit of Clinical and Molecular Hepatology, Department of Internal Medicine, University of Messina, Italy.

Annals of Hepatology
|July 13, 2005
PubMed

Insights

Hepatitis B (HBV) and hepatitis C (HCV) coinfection, including occult HBV, is common and clinically relevant. Further research is needed to understand the interplay between these viral infections.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) share transmission routes, leading to frequent coinfections, especially in endemic areas.
  • Occult HBV infection, characterized by HBV genomes in HBsAg-negative individuals with HCV, is more prevalent than often recognized.
  • Dual HBV/HCV infections, including occult HBV, are associated with accelerated liver fibrosis, cirrhosis, and hepatocellular carcinoma.

Purpose of the Study:

  • To review the available data on the virological and clinical features of dual HBV/HCV infection.
  • To highlight key areas for future research on HBV/HCV coinfection.
  • To improve understanding of the interplay between HBV and HCV in coinfected patients.

Main Methods:

  • Literature review of existing studies on HBV/HCV coinfection.
  • Analysis of virological and clinical data from coinfected patients.
  • Identification of knowledge gaps in the field of hepatology concerning dual viral infections.

Main Results:

  • Coinfection with HBV and HCV, including occult HBV, is a significant clinical concern.
  • The interplay between HBV and HCV in coinfection requires further investigation.
  • Dual infections can promote liver disease progression.

Conclusions:

  • Dual HBV/HCV infection, encompassing overt and occult HBV, has substantial clinical implications.
  • More research is essential to elucidate the complex interactions between HBV and HCV.
  • Understanding these viral dynamics is crucial for advancing hepatology and patient care.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...